Major Depressive Disorder
Major Depressive Disorder (MDD), commonly referred to as clinical depression or major depression, is a mental health condition characterized by persistent feelings of sadness, hopelessness, and a loss of interest or pleasure in activities. It is a serious and debilitating condition that affects a person’s emotions, thoughts, and behaviors.
The exact cause of major depressive disorder is not fully understood, but it is believed to involve a complex interaction of genetic, biological, environmental, and psychological factors. Certain risk factors may increase the likelihood of developing depression, including a family history of the disorder, personal history of other mental health conditions, traumatic life events, chronic illness, substance abuse, and certain medications.
This magazine contains content which is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Major Depressive Disorder.
-
Publication date: Mar 14, 2026 To investigate, with an emphasis on possible nonlinearity, the relationship ...
-
Local Hyperexcitability and Long-Range Hypocommunication in the Low-Gamma Band Characterize Major Depressive Disorder with Mixed Features.
Publication date: May 12, 2026 Major depressive disorder with mixed features (DMF) is a severe ... -
Comparative multidimensional psychosocial profiles of major depressive disorder patients with higher versus lower anhedonia burden: a cross-sectional study.
Publication date: May 12, 2026 Anhedonia is a core symptom of major depressive disorder (MDD) ... -
Blunted anticipation, but not consummation, of food rewards in depression.
Publication date: May 12, 2026 Anhedonia is a core symptom of major depressive disorder (MDD) ... -
Cheek acupuncture can improve the depressive and anxious symptoms of patients with moderate depression disorders.
Publication date: May 12, 2026 Through a randomized controlled clinical trial, the clinical efficacy of ... -
Evaluation of glymphatic system activity by using diffusion tensor image analysis along the perivascular space in patients with differential suicidality.
Publication date: May 12, 2026 Glymphatic dysfunction is linked to various neurological conditions, yet its ... -
The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis.
Publication date: May 13, 2026 Major depressive disorder (MDD) represents a leading cause of disability. ... -
Thalamic nuclei volumes across psychiatric and neurological disorders: a multi-site magnetic resonance imaging study.
Publication date: May 13, 2026 The human thalamus is an integrative hub for multiple cortical ... -
Bridging molecules and connectome: network biomarkers guided by neurotransmitter architecture in major depressive disorder.
Publication date: May 13, 2026 Major depressive disorder (MDD) involves multiscale alterations ranging from molecular ... -
Nationwide Transdiagnostic Age and Sex Patterns in Mental Disorder Disease Development.
Publication date: May 13, 2026 Individuals with mental disorders often experience multiple disease episodes and ... -
Application of escitalopram population pharmacokinetic repository: a step to precision dosing.
Publication date: May 13, 2026 Escitalopram is widely used to treat major depressive disorder, yet ... -
Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial – CORRIGENDUM.
Publication date: May 13, 2026 Open Access PDF Concepts Keywords Bjpsych Blind Depressive Controlled Psilocybin ... -
Determinants of Sustainable Return to Work After Burnout or Depression: A Longitudinal Cohort Study.
Publication date: May 13, 2026 People with common mental disorders (CMDs) such as depression and ... -
Acute placebo responsiveness predicts longitudinal expectation effects in antidepressant treatment.
Publication date: May 13, 2026 Positive treatment expectations are known to enhance antidepressant efficacy. Experimental ... -
Cognitive fusion as a mediator between pain interference and depressive and anxiety symptoms among adults with spinal cord injury.
Publication date: May 13, 2026 This study examined whether cognitive fusion statistically mediated the cross-sectional ... -
iCARE Self-Guided Digital Intervention for Postpartum Depression in Danish Mothers: Formative Research Using User-Centered Design.
Publication date: May 13, 2026 Postpartum depression (PPD) is a major public health concern. Despite ... -
Machine Learning for Comparative Antidepressant Selection in Major Depressive Disorder: Systematic Review.
Publication date: May 13, 2026 Major depressive disorder (MDD) affects approximately 1 in 6 adults ... -
Incomplete network restoration may be associated with higher relapse risk in women with major depressive disorder.
Publication date: May 13, 2026 This study aimed to examine sex-specific alterations in structural brain ... -
Network structure of reward sensitivity and its temporal interactions with depression: a cross-lagged panel network analysis.
Publication date: Jun 01, 2026 Reward sensitivity plays a crucial role in shaping emotional and ... -
Depression stigma and alcohol use among adults with major depressive disorder: a daily diary study.
Publication date: May 10, 2026 The comorbidity between depression and alcohol use problems is well-documented, ... -
Shouhui Tongbian Capsule Is Associated with Antidepressant-Like Effects and Gut-Brain Axis-Related Biological Improvements in Mouse Models of Depression.
Publication date: May 10, 2026 Major depressive disorder (MDD) is a global health challenge with ...